Synthesis, characterization and evaluation of derivative of Ciprofloxacin (1-cyclopropyl-6-fluoro-4-oxo-7-[4-(phenyl carbonyl) piperazin-1-yl]-1, 4-dihydroquinoline-3-carboxylic acid) and their complexes

Journal of Chemical and Pharmaceutical Research

Volumn 3, Issue 5, 2011, Pages 390-398

  Thakre, Y M ^a   Choudhary, M D ^b  

^a Datta Meghe Institute of Engineering   (India)

^b BDCOE   (India)

Author keywords

Antimicrobial activity; Fluoroquinolines; Synthesis

Indexed keywords

1 CYCLOPROPYL 6 FLUORO 4 OXO 7 [4 (PHENYL CARBONYL) PIPERAZIN 1 YL] 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID; CARBON; CIPROFLOXACIN; HYDROGEN; METAL ION; NITROGEN; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACILLUS; CANDIDA ALBICANS; COMPLEX FORMATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ELEMENT ANALYSIS; ESCHERICHIA COLI; INFRARED SPECTROPHOTOMETRY; KLEBSIELLA PNEUMONIAE; LIPOPHILICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PSEUDOMONAS; SALMONELLA; SALMONELLA TYPHI; SHIGELLA DYSENTERIAE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

EID: 80053513790     PISSN: None     EISSN: 09757384     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. BN Lomaestero; G R Bailie; Ann, Pharmacother. 1991, 25, 1249-1558.
2. JH Paton; DS Reeves; Drugs 1988, 36, 193-228
3. M Gellert; K Mizuuchi; MO Dea; H Nash, Proc. Natl. Acad. Sci. USA 1976, 73, 3872-3876.
4. M Gellert; K Mizuuchi; MO Dea; T. Itoh, J. Tomizawa, Proc. Natl. Acad. Sci., USA 1977, 74,4772-4776.
5. M Gillert; An Rev; Biochem., 1981,50, 879-910.
6. NR Cozarelli, Science., 1980, 207, 953-960.
7. G Palu; S Valisena; G Ciarrocchi; B Gatto; M Palumbo; Proc. Natl. Acad. Sci. USA., 1992, 89,9671-9675.
8. RW Frost; JD Carlson; AJ Dietz; A Heyd; JT Lettieri; J. Clin.Pharmacol., 1989, 29, 953-955.
9. DE Nix; WA Watson; ME Lener; RW Frost; G Krol; H Goldstein; J. Lettieri, Clin. Pharmacol.,Ther. 1992, 46, 830-836.
10. RW Frost; KC Leasseter; AJ Noe; EC Shamblen; JT Lettieri; Antimicrob. Agents Chemother.,1992, 36, 830-832.
11. RE Polk; DP Healy; J Sahai; L drawl; E Racht; Antimicrob. Agents Chemother., 1989, 33,
12. 18411844.
13. M Kara; BB Hasinoff; DW Mckay; NRC Campell; Brit. J. Clin. Pharmac., 1991, 31, 257-261.
14. T Motoya; M Niyashita; A Kawachi; K Yamada; J. Pharm. Pharmacol., 2000, 52, 397-401.
15. JRJ Sorenson; J. Med. Chem., 1976, 19, 135-148.
16. DH Brown; AJ Lewis; WE Smith; JW Teape., J. Med. Chem. 1980, 23, 729-734.
17. DR Williams. The Metals of Life, Van Nostrand Reinhold: London, 1971.
18. M Ruiz; L Perello; R Ortiz; A Castineiras; C Maichlemossmer; J. Inorg. Biochem.,1995, 59, 801-810.
19. SE Castillo-Blum; N Barba-Behrens; Coord. Chem. Rev. 2000, 196, 3-30.
20. th edit,Wiley,1991.
21. I Turel; P Bukovec; M Quiros, Int. J.Pharm., 1997, 152, 59-65.
22. YM. Thakre, MD Choudhary; RD Raut. Synthesis and evaluation of Ciprofloxacin complexes as diagnostic tools for bacterial infection. International conference. Innovative ideas2011.
23. JE Morris; XS Pan; LM Fisher, Antimicrobial Agents and Chemotherapy, February 2002, p. 582-585, Vol. 46, No.